ANDA 77138, held by Teva Pharms. Ciprofloxacin.
As of Nov 15, 2026, ANDA 77138 (Ciprofloxacin In Dextrose 5% In Plastic Container), held by Teva Pharms, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 21, 2005 | Original application | Tentative approval |
| Ciprofloxacin In Dextrose 5% In Plastic Container200MG/100ML · injectable;injection | Ciprofloxacin | Discontinued |
| Ciprofloxacin In Dextrose 5% In Plastic Container400MG/200ML · injectable;injection | Ciprofloxacin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
